Home Newsfeeds GE Gas Power Awarded $4.2M In Funding From ARPA-E To Develop Decarbonization Technologies

GE Gas Power Awarded $4.2M In Funding From ARPA-E To Develop Decarbonization Technologies

https://www.ge.com/news/press-releases/ge-gas-power-awarded-42-million-in-funding-from-arpa-e-to-develop-breakthrough

byBenzinga Newsdesk

July 28, 2022

1 minute read

https://www.ge.com/news/press-releases/ge-gas-power-awarded-42-million-in-funding-from-arpa-e-to-develop-breakthrough

AMN Healthcare Acquires MSDR For $300M, Expanding Locum Tenens Potential And Bolstering Talent Pool

By Akanksha Bakshi

October 23, 11:04 AM

AMN Healthcare Services Inc (NYSE: AMN), a total talent solutions provider for healthcare organizations, has

AMN

Immuneering Will Be Presenting Preclinical Data On Its Lead Program IMM-1-104 At American Association For Cancer Research Showing Broad Response Demonstrated Through Deep Cyclic Inhibition Of MAPK Pathway, Independent Of Specific RAS Mutation

By Benzinga Newsdesk

March 6, 4:50 AM

Phase 1/2a clinical trial with IMM-1-104 is underway in patients with advanced solid tumors harboring RAS mutations.

IMRX

Elon Musk’s Tesla Is Now A ‘Meme Stock,’ Says Economist: ‘The Market Does Not Particularly Care’

By Benzinga Neuro

May 3, 4:04 AM

Elon Musk's Tesla has been labeled a "meme stock" by a renowned economist, who believes that the company's success is now more about Musk's promises than its actual performance.

STLA

Analyst Views West Pharmaceutical’s Q4 Earnings Impressive Despite Headwinds

By Vandana Singh

February 16, 1:48 PM

West Pharmaceutical Services Inc (NYSE:WST) reported Q4 2022 net sales of $708.7 million, down 3%, and organic net sales growth…

WST

GE Gas Power Awarded $4.2M In Funding From ARPA-E To Develop Decarbonization Technologies

Related Posts

AMN Healthcare Acquires MSDR For $300M, Expanding Locum Tenens Potential And Bolstering Talent Pool

Immuneering Will Be Presenting Preclinical Data On Its Lead Program IMM-1-104 At American Association For Cancer Research Showing Broad Response Demonstrated Through Deep Cyclic Inhibition Of MAPK Pathway, Independent Of Specific RAS Mutation

Elon Musk’s Tesla Is Now A ‘Meme Stock,’ Says Economist: ‘The Market Does Not Particularly Care’

Analyst Views West Pharmaceutical’s Q4 Earnings Impressive Despite Headwinds